DIMENSIONAL FUND ADVISORS LP
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 354204
AUSTIN, TX
Position in REGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$348,987,230
-$47,423,446 QoQ
Shares Held
559,687
+9.1% QoQ
Ownership
0.544%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#29
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 81%
Shared 10%
None 9%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. REGN ranks #3 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $348,987,230 | 559,687 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $396,410,676 | 513,060 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $385,583,025 | 499,544 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $280,626,705 | 499,096 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $272,704,425 | 519,437 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $362,263,928 | 571,187 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $418,155,515 | 587,025 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $599,274,077 | 570,064 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $616,494,257 | 586,562 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $566,861,371 | 588,953 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $521,284,435 | 593,522 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $509,631,145 | 619,266 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $440,338,555 | 612,824 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $520,534,515 | 633,508 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $457,848,894 | 634,588 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $448,045,867 | 650,407 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $373,538,591 | 631,906 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $408,679,764 | 585,149 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $317,337,536 | 502,498 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $244,208,285 | 403,530 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $178,874,669 | 320,254 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $118,354,551 | 250,147 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $114,421,221 | 236,843 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $125,874,929 | 224,865 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $134,960,978 | 216,405 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $102,155,150 | 209,210 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||